CoDx (CODX) Price to Earnings Ratio

Corporate emblem and logo of Co-Diagnostics Corp (CODX)

The market value of Co-Diagnostics, Inc. (CODX) on the GURU.Markets platform, where the PE ratio stands at -0.10, as illustrated on this chart, characterizes the health diagnostics business. Co-Diagnostics, Inc. (CODX) remains resilient to market volatility, leveraging the success of new products and tests. Proprietary rights to CoPrime and strict FDA oversight create a high barrier to entry. Additionally, the firm is implementing green packaging and energy efficiency to comply with ESG standards.

CODX Co-Diagnostics: Price to Earnings Ratio in the range 07/04/2022 - 11/12/2026

Analytical breakdowns for Co-Diagnostics, Inc.

- price and consensus price forecast:
Stock Price codiagnostics.com|CODX - Price Target Chart
- market capitalization details:
Market Value Co-Diagnostics, Inc.|CODX - Real Price to Acquire Entire Company
- book capitalization information:
Net Asset Value per Share Co-Diagnostics|CODX - Company Book Value|Market Capitalization to Book Value codiagnostics.com|CODX - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Co-Diagnostics, Inc.|CODX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient CoDx|CODX - Company Aggregate Debts|Debt to Book Value Co-Diagnostics, Inc.|CODX - Company Long-Term Debt|Short-Term Debt Co-Diagnostics|Critical Liquidity codiagnostics.com
- business earnings and investment ratios data:
CODX - Net Profit|Net Profit Forecast Co-Diagnostics, Inc.|CODX - P/E Multiple|Market Cap to Projected Earnings Co-Diagnostics Inc|CODX - PEG Multiple|EV/EBITDA Multiple Co-Diagnostics, Inc.|CODX - Operating profit EBITDA|Net earnings per share for the trailing year Co-Diagnostics|CODX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months codiagnostics.com|CODX - Earnings per share growth in current year|Expected net earnings per share growth next year Co-Diagnostics, Inc.
Summary company analysis:CODX codiagnostics.com
Manufactured product of Co-Diagnostics, Inc.

Institutional capital assesses the investment attractiveness of Co-Diagnostics, Inc. (CODX) through the price-to-earnings ratio, which determines the payback period for investments in the molecular diagnostics business. By analyzing the P/E ratio based on net income, investors can see how the diversification of PCR tests for the medical and agricultural sectors impacts fundamental value, confirming the asset's resilience amid price volatility.

Analysis of competing companies

P/E Multiple agilent.com|Price to Earnings Ratio Quest Diagnostics Incorporated (DGX)|Price to Earnings Ratio ILMN (Illumina Inc)|Cologuard - Price to Earnings Ratio|Revvity Corp (RVTY) - Market Cap to Earnings|BIO - Price to Earnings Ratio|Business Payback Period anbio.com NNNN|SHC: P/E Multiple|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Corp|caredx.com (CDNA) - Business Payback Period|P/E Multiple MRVI|Price to Earnings Ratio fulgentgenetics.com FLGT|Price to Earnings Ratio Standard BioTools LAB|Cytek Biosciences Inc (CTKB) - Market Cap to Earnings|OSUR: Price to Earnings Ratio|Market Cap to Net Income Ratio Exagen Inc. (XGN)|MDXH: P/E Multiple|Price to Earnings Multiple LUCD|PRE (Prenetics Global Limited) - P/E Multiple|Insight Molecular (IMDX) - Business Payback Period|P/E Multiple TRIB|P/E Multiple ProPhase Labs Corp (PRPH)|P/E Multiple AIMD (Ainos, Inc.)|Market Cap to Net Income Ratio heartsciences.com|BMRA - Price to Earnings Ratio|CDIO (Cardio Diagnostics) - Price to Earnings Multiple|Onconetix Corp (ONCO) - Price to Earnings Ratio|Market Cap to Earnings Virax Biolabs Corp (VRAX)|Price to Earnings Ratio Bluejay Diagnostics|aspirawh.com (AWH) - Business Payback Period|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc.)|Market Price to Net Income Ratio CNTG|P/E Multiple ENZ (Enzo Biochem)|Business Payback Period Fresh2 Group Ltd (FRES)|GTG Labs - P/E Multiple|23andme.com (ME) - Price to Earnings Ratio|Psychemedics Corporation (PMD) - Price to Earnings Ratio